SCHEMBL6904172

SCHEMBL6904172

Cc1cc(=O)oc2cc(O)c(N)cc12

nearest known ligand 0.74

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 8/20 0.74
HSD17B10 Q99714 8/20 0.74
KDM4E B2RXH2 7/20 0.74
HPGD P15428 7/20 0.74
MCL1 Q07820 4/20 0.74
AKR1B1 P15121 2/20 0.74
CYP3A4 P08684 2/20 0.74
THRB P10828 1/20 0.74
HTT P42858 1/20 0.62
NCOA3 Q9Y6Q9 1/20 0.62
GAA P10253 5/20 0.56
CASP1 P29466 5/20 0.56
CASP7 P55210 5/20 0.56
CA9 Q16790 4/20 0.56
GLA P06280 3/20 0.56
CA12 O43570 2/20 0.56
CYP1A2 P05177 2/20 0.56
CA1 P00915 2/20 0.56
LMNA P02545 1/20 0.56
CYP2C9 P11712 1/20 0.56

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
4-Methylesculetin SCHEMBL409482 0.85 MCL1 (1.00) ALDH1A1HSD17B10KDM4EHPGDMCL1
SCHEMBL30450241 0.85 KDM4E (0.62) ALDH1A1HSD17B10KDM4EHPGDMCL1
SCHEMBL29061776 0.85 KDM4E (0.62) ALDH1A1HSD17B10KDM4EHPGDMCL1
4-Methylesculetin SCHEMBL29361762 0.85 MCL1 (1.00) ALDH1A1HSD17B10KDM4EHPGDMCL1
SCHEMBL24865598 0.84 ALDH1A1 (0.82) ALDH1A1HSD17B10KDM4EHPGDMCL1
4-Methylesculetin SCHEMBL27453331 0.84 ALDH1A1 (0.96) ALDH1A1HSD17B10KDM4EHPGDMCL1
4-Methylesculetin SCHEMBL6839210 0.84 MCL1 (0.96) ALDH1A1HSD17B10KDM4EHPGDMCL1
SCHEMBL31736933 0.84 KDM4E (0.61) ALDH1A1HSD17B10KDM4EHPGDMCL1
SCHEMBL11235774 0.80 KDM4E (0.61) ALDH1A1HSD17B10KDM4EHPGDMCL1
SCHEMBL31357189 0.79 MCL1 (1.00) ALDH1A1HSD17B10KDM4EHPGDMCL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-106083889-B Yi Lei oxazoles and application of the coumarin derivative in terms of pesticide 青岛农业大学 2018-07-06 CN disclosed
CN-106083889-A One class azoles coumarin derivative application in terms of pesticide 青岛农业大学 2016-11-09 CN disclosed
US-20040053893-A1 Method of assaying iysophospholipase d activity AZWELL INC. (JP) 2004-03-18 US disclosed
EP-1357126-A1 METHOD OF ASSAYING LYSOPHOSPHOLIPASE D ACTIVITY Azwell Inc. (JP) 2003-10-29 EP disclosed
CN-1117035-C Water treatment agent NIPPON CATALYTIC CHEM IND (JP) 2003-08-06 CN disclosed
EP-0761604-B1 An agent for water treatment NIPPON CATALYTIC CHEM IND (JP) 2000-06-14 EP disclosed
US-5948268-A DISSOLVING IN WATER TO BE TREATED A POLYMER FORMED FROM WATER SOLUBLE MONOMER UNITS COMPRISING A (POLY)ALKYLENE OXIDE END CAPPED WITH AN ADDITION POLYMERIZABLE GROUP AT ONE END AND AN INTENSELY FLUORESCENT GROUP AT OTHER NIPPON SHOKUBAI CO., LTD. (JP) 1999-09-07 US disclosed
CN-1151380-A Water treatment agent NIPPON CATALYTIC CHEM IND (JP) 1997-06-11 CN disclosed
EP-0761604-A2 An agent for water treatment NIPPON SHOKUBAI CO., LTD. (JP) 1997-03-12 EP disclosed
EP-0485882-A1 A polymer utilized in water system and a method of treatment of water system KURITA WATER INDUSTRIES LTD. (JP) 1992-05-20 EP disclosed
US-5011964-A Phospholipase cleavage of water-insoluble ester yields chromogen for colorimetric analysis CORNELL RESEARCH FOUNDATION, INC. (US) 1991-04-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040053893-A1 Method of assaying iysophospholipase d activity LYPLA1, LPL, LYPLA2 ALDH1A1 717/4885HSD17B10 242/4885KDM4E 3867/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.